Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
Avatar

New Therapeutic Targets Beyond JAK-STAT Inhibition in the Treatment of Ph-Negative MPN: Should We Be Moving Away?

By Cleveland Clinic Taussig Cancer Institute FEATURING Aaron Gerds
By Cleveland Clinic Taussig Cancer Institute FEATURING Aaron Gerds
399 views
January 27, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh
MDS/MPN
10:06

New Therapeutic Targets Beyond JAK-STAT Inhibition in the Treatment …

Cleveland Clinic Taussig Cancer Institute

A. Gerds

399 views
16:58

JAK-STAT Inhibition in the Treatment of Ph-Negative MPN: What Are th…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

264 views
30:31

Somatic Mutations in MDS as a Diagnostic (ICUS, CHIP, CCUS) and Prog…

Cleveland Clinic Taussig Cancer Institute

V. Santini

140 views
28:01

The Changing Genomic Landscape of MPNs: Impact on Clinical Care

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

162 views
07:40

MPN, MDS and Aplastic Anemia Case Discussions

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

426 views
28:08

Rationale and Early Results of Innate Immunity and Immune Check Poin…

Cleveland Clinic Taussig Cancer Institute

G. Garcia-Manero

117 views
14:50

Novel Therapies Beyond Single Agent JAK Inhibitors: New Therapies an…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

302 views